These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 26004783)

  • 21. Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology.
    Reed DS; Lackemeyer MG; Garza NL; Sullivan LJ; Nichols DK
    Microbes Infect; 2011 Oct; 13(11):930-6. PubMed ID: 21651988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current ebola vaccines.
    Hoenen T; Groseth A; Feldmann H
    Expert Opin Biol Ther; 2012 Jul; 12(7):859-72. PubMed ID: 22559078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
    Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY
    J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.
    Warfield KL; Swenson DL; Olinger GG; Kalina WV; Aman MJ; Bavari S
    J Infect Dis; 2007 Nov; 196 Suppl 2():S430-7. PubMed ID: 17940980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against Sudan ebolavirus and Marburg virus.
    Wolfe DN; Taylor MJ; Zarrabian AG
    Hum Vaccin Immunother; 2020 Nov; 16(11):2855-2860. PubMed ID: 32275465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical features and pathobiology of Ebolavirus infection.
    Ansari AA
    J Autoimmun; 2014 Dec; 55():1-9. PubMed ID: 25260583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mission critical: mobilization of essential animal models for Ebola, Nipah, and Machupo virus infections.
    Zumbrun EE
    Vet Pathol; 2015 Jan; 52(1):18-20. PubMed ID: 25352204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of vaccines for prevention of Ebola virus infection.
    Ye L; Yang C
    Microbes Infect; 2015 Feb; 17(2):98-108. PubMed ID: 25526819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ebolavirus: An Overview of Molecular and Clinical Pathogenesis.
    Vine V; Scott DP; Feldmann H
    Methods Mol Biol; 2017; 1628():39-50. PubMed ID: 28573609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of experimental and early investigational drugs for the treatment of Ebola virus infections.
    Wong G; Qiu X
    Expert Opin Investig Drugs; 2015; 24(8):999-1011. PubMed ID: 26065319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of the Syrian hamster as a new model of ebola virus disease and other viral hemorrhagic fevers.
    Wahl-Jensen V; Bollinger L; Safronetz D; de Kok-Mercado F; Scott DP; Ebihara H
    Viruses; 2012 Dec; 4(12):3754-84. PubMed ID: 23242370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed Disease Progression in Cynomolgus Macaques Infected with Ebola Virus Makona Strain.
    Marzi A; Feldmann F; Hanley PW; Scott DP; Günther S; Feldmann H
    Emerg Infect Dis; 2015 Oct; 21(10):1777-83. PubMed ID: 26402165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ebola virus: unravelling pathogenesis to combat a deadly disease.
    Hoenen T; Groseth A; Falzarano D; Feldmann H
    Trends Mol Med; 2006 May; 12(5):206-15. PubMed ID: 16616875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of clinical and immunological parameters during Ebola virus infection of rhesus macaques.
    Martins K; Cooper C; Warren T; Wells J; Bell T; Raymond J; Stuthman K; Benko J; Garza N; van Tongeren S; Donnelly G; Retterer C; Dong L; Bavari S
    Viral Immunol; 2015 Feb; 28(1):32-41. PubMed ID: 25514385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of ebola virus disease.
    Kilgore PE; Grabenstein JD; Salim AM; Rybak M
    Pharmacotherapy; 2015 Jan; 35(1):43-53. PubMed ID: 25630412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Animal models for Ebola and Marburg virus infections.
    Nakayama E; Saijo M
    Front Microbiol; 2013 Sep; 4():267. PubMed ID: 24046765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus.
    Cross RW; Mire CE; Borisevich V; Geisbert JB; Fenton KA; Geisbert TW
    J Infect Dis; 2016 Aug; 214(4):565-9. PubMed ID: 27354371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Animal models for filovirus infections.
    Siragam V; Wong G; Qiu XG
    Zool Res; 2018 Jan; 39(1):15-24. PubMed ID: 29511141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ebola and Marburg hemorrhagic fever viruses: update on filoviruses].
    Leroy E; Baize S; Gonzalez JP
    Med Trop (Mars); 2011 Apr; 71(2):111-21. PubMed ID: 21695865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental Respiratory Infection of Marmosets (Callithrix jacchus) With Ebola Virus Kikwit.
    Smither SJ; Nelson M; Eastaugh L; Nunez A; Salguero FJ; Lever MS
    J Infect Dis; 2015 Oct; 212 Suppl 2():S336-45. PubMed ID: 26209682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.